Ipsen Group - Company & Market Research Reports

Home /
Companies /
Ipsen Group

Ipsen is a global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases. The company offers drugs in urology – oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology, and cardiovascular areas. Its products include Decapeptyl, Hexvix, Somatuline, NutropinAq and Dysport. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 84
Central Nervous System Drugs 66
Endocrine and Metabolic Disorders Drugs 50
Infusions and Injectables 32
Musculoskeletal Disorders Drugs 27
Surgical Procedures 21
Pharmaceuticals 20
Drug Discovery 15
Biopharmaceuticals 15
Drug Delivery 13
Prostate Cancer Drugs 12
Liver Cancer Drugs 10
Women's Health 10
Dermatology 10
Oncology 10
Neurology 9
Pancreatic Cancer Drugs 9
Clinical Trials 8
Medical Devices 8
Thyroid Cancer Drugs 8
Biotechnology 7
Lung Cancer Drugs 7
Healthcare Services 6
Breast Cancer Drugs 6
Genomics 6
Diagnostics 6
Gastrointestinal Drugs 6
Liver and Kidney Disorders Drugs 6
Company Reports 5
Immune Disorders Drugs 5
Kidney Cancer Drugs 5
Dermatological Drugs 5
Urology and Nephrology 4
Enzymes 4
Sexual and Reproductive Health Drugs 4
Therapeutic Area 3
Drugs by Therapeutic Area 3
Cardiovascular Drugs 3
Ovarian Cancer Drugs 3
Colon Cancer Drugs 3
Bladder Cancer Drugs 3
Managed Care 3
Surgical Devices 3
Over the Counter (OTC) Drugs 3
Urological Disorders Drugs 3
Optical Disorders Drugs 2
Lymphoma Drugs 2
In Vitro Diagnostics 2
Hematology 2
Hematological Drugs 2
Biosimilars and Biosuperiors 2
Laboratory Equipment 2
Pediatrics 2
Gastroenterology 2
Pharmaceutical Intermediates 1
Allergy and Immunology 1
Infectious Diseases Drugs 1
Leukemia Drugs 1
Cervical Cancer Drugs 1
Brain Cancer Drugs 1
Point-of-Care Diagnostics 1
Infectious Disease Testing 1
Analgesics 1
Healthcare 1
Transdermal and Transmucosal Drug Delivery 1
Needles and Syringes 1
Nuclear Medicine and Radiopharmacology 1
Skin Cancer Drugs 1
Anti-Obesity Drugs 1
Intensive Care and Emergency Medicine 1
Endocrinology 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



284 reviews

445 Results (Page 5 of 23)
- Relevance
  Sort by

Kidney Cancer Diagnostics and Therapeutics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4017EUR$4,490USD£3,436GBP

Selective Estrogen Receptor Modulators Market - Global Forecast 2025-2030

 Report
August 2025
190 Pages
Global

From

€3172EUR$3,545USD£2,713GBP

€3524EUR$3,939USD£3,014GBP

Endometriosis Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Endometriosis Type, By Diagnostic Method, By Treatment Method, By Drug Category, By Diagnostics Type, By Distribution Channel, By End-User, Company, Region

 Report
November 2022
111 Pages
Global

From

€4026EUR$4,500USD£3,443GBP

Pancreatic Endocrine Tumor Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
89 Pages
Global

From

€3500EUR$4,190USD£3,098GBP

Triptorelin acetate Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
April 2023
86 Pages
Global

From

€3500EUR$4,190USD£3,098GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

The Corporate Reputation of Pharma in 2021 - the Patient Perspective - Rare Disease Edition - The Views of 303 Rare-Disease Patient Groups

 Report
October 2022
58 Pages
Global

€9682EUR$11,200USD£8,000GBP

Bromhidrosis Disease Treatment - Global Strategic Business Report

 Report
August 2026
224 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Rare Endocrine Disease Treatment - Global Strategic Business Report

 Report
August 2026
194 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Addison's Disease Therapeutics Market - Global Strategic Business Report

 Report
August 2026
278 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Acromegaly Treatment - Global Strategic Business Report

 Report
August 2026
297 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Growth Hormone Deficiency Market - Global Strategic Business Report

 Report
August 2026
475 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Endocrinology Drugs Market - Global Strategic Business Report

 Report
August 2026
288 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Dystonia Drugs Market - Global Strategic Business Report

 Report
August 2026
369 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Cervical Dystonia Treatment - Global Strategic Business Report

 Report
August 2026
282 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Skeletal Dysplasia Market - Global Forecast 2026-2032

 Report
August 2026
194 Pages
Global

From

€3172EUR$3,545USD£2,713GBP

€3524EUR$3,939USD£3,014GBP

Human Growth Hormone Market Size, Share & Trends Analysis Report by Product Type, Application, Dosing Frequency, Distribution Channel, Region, and Segment Forecasts, 2026-2040

 Report
January 2026
150 Pages
Global

From

€5324EUR$5,950USD£4,553GBP

Fibrodysplasia Ossificans Progressiva Market - Global Forecast 2026-2032

 Report
January 2026
185 Pages
Global

From

€3172EUR$3,545USD£2,713GBP

€3524EUR$3,939USD£3,014GBP

Combination Product Services Market by Type of Device Service Focus Area, Company Size, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

 Report
August 2022
212 Pages
Global

From

€4294EUR$4,799USD£3,672GBP

Botulinum Toxins Market - Global Forecast 2026-2032

 Report
August 2026
192 Pages
Global

From

€3172EUR$3,545USD£2,713GBP

€3524EUR$3,939USD£3,014GBP

Insulinoma Treatment - Global Strategic Business Report

 Report
August 2026
320 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

445 Results (Page 5 of 23)
- 1
- 3
- 4
- 5
- 6
- 7

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.